Preempt future health risks.
The world’s most trusted independent health intelligence, cited over 16,000 times in 2022
Analysis & Insights
Former Editor of The Economist joins Airfinity as advisor
Bill Emmott, former Editor-in-Chief at The Economist, joins Airfinity’s advisory board as the company expands its global public health data offering.
Read More →More from Airfinity
China to see one longer, more severe COVID wave as Lunar Festival fuels outbreakAirfinity hosting industry leader roundtable on the future of the RSV marketChina’s COVID-19 wave forecast to have two peaks where cases could reach 4.2 million a dayAirfinity launches intelligence tool to drive innovation in AMR researchIntroducing Airfinity Biorisk: Risk Surveillance and Analytics for 160+ Infectious DiseasesAstraZeneca’s infant RSV drug Beyfortus could generate $1.1bn sales revenueView All →In the News
The next generation of coronavirus vaccines: a graphical guideNature | Feb 1, 2023
China, speeding through phases of covid, gets on with living with virusThe Washington Post | Jan 27, 2023
China celebrates lunar new year as Covid infections hit 80%Financial Times | Jan 22, 2023
China plays down COVID outbreak with holiday rush at full tiltReuters | Jan 20, 2023
View All →
A pioneer in predictive health intelligence
Understand
What's happening in a given disease area?
Airfinity is the most comprehensive, single source of intelligence for new developments in your chosen area.
Predict
Identify the true need for a vaccine or a treatment.
Our suite of dynamic predictive indicators help you navigate highly dynamic and uncertain market developments and see the real opportunities.
Act
Maximise impact to save lives
Our analytics and probabilistic tools inform key decisions on resource allocation, investment and procurement decisions to maximise impact of a given drug or vaccine and ultimately improve as many lives as possible.
The world's most comprehensive infectious disease solutions.
Airfinity combines proprietary surveillance tools and forecast models with expert analysis for dozens of infectious diseases, including COVID-19, Monkeypox, Influenza and RSV.
OUR PLATFORM:
New science
Market & Production
Policies
Disease & Prevalence
What our users say?
“The Airfinity report is a guide for world leaders to fix a more ambitious action plan.”
Gordon Brown, WHO Ambassador for Global Health Financing & former UK Prime Minister
“Airfinity has been instrumental in our country's COVID response.”
Head of UK Government
Vaccine Task Force
“Vaccine production data from Airfinity has been spot on. In a fast moving pandemic, these forecasts are really important for evidence-based policy making.”
Director General,
IFPMA
“Airfinity has been critical in furnishing us and the rest of the world with COVID-19 numbers.”
James Fransham, Data Journalist,
The Economist